ANA Clinical Trials Course
The ANA Clinical Trials Course is designed to further the career development of clinical neurologists interested in conducting clinical research. Compared to fields such as oncology and cardiology, the clinical neurosciences often lack well established pathways for providing this kind of training for emerging clinician-scientists. This day-long course will engage academic neurologists and neuroscientists in an analysis of the clinical development and testing of therapies for neurological diseases. Most participants will not have yet developed long-term clinical research programs or funding, but they will have intentions to work in this area. Throughout the course, strategies for career development will be interwoven with the didactic material, and the day will include time for networking with other participants and speakers.
This course is designed to support academic neurologists and neuroscientists at every stage of their career.
COURSE SCHEDULE
Note: All session times are listed in Eastern Daylight Time (EDT).
Schedule Subject to Change: The event’s operating hours, schedules, CME and speakers are subject to change or cancellation without notice. Refunds will be not issued for failure to attend the session.
COURSE MODERATORS
Craig D. Blackstone, MD, PhD, FANA, Clinical Trials 2025 Co-Director; Professor of Neurology, Harvard Medical School; Chief, Movement Disorders Division, Massachusetts General Hospital, Boston
SATURDAY, SEPTEMBER 13, 2025
8:00 AM – 8:15 AM | Introduction Chair: Craig Blackstone, MD, PhD, FANA | Massachusetts General Hospital |
8:15 AM – 9:00 AM | Producing Neurologic Therapies: Present and Future Speaker: Walter Koroshetz, MD, FANA | National Institute of Neurological Disorders and Stroke; National Institutes of Health |
9:00 AM – 9:30 AM | Intro to Clinical Study Design Speaker: Pooja Khatri, MD, MSc | Yale University |
9:30 AM – 10:00 AM | How to Do Translational Neurology in Academia Speaker: Kevin Sheth, MD, FANA | Yale School of Medicine |
10:00 AM – 10:30 AM | Break |
10:30 AM – 11:00 AM | Development of Targeted Therapies for Parkinson’s Disease Speaker: Dimitri Krainc, MD, PhD, FANA | Northwestern University |
11:00 AM – 11:30 AM | How to Get (and Stay) Funded Speaker: Justin McArthur, MBBS, MPH, FAAN, FANA | Johns Hopkins School of Medicine |
11:30 AM – 12:00 PM | New Approaches to Clinical Trials Speaker: Sabrina Paganoni, MD, PhD | Massachusetts General Hospital |
12:00 PM – 1:00 PM | Lunch |
1:00 PM – 1:30 PM | Using the CTSA System Effectively Speaker: Anthony Kim, MD, MAS | University of California, San Francisco |
1:30 PM – 2:00 PM | Accelerating Clinical Research with Internet Recruitment and Direct To Participant Trials Speaker: Caroline Tanner, MD, PhD, FANA | University of California, San Francisco |
2:00 PM – 2:15 PM | Break |
2:15 PM – 2:45 PM | Starting and Developing a Successful Career as a Clinical Trialist Speaker: Amanda Guidon, MD, MPH | Massachusetts General Hospital |
2:45 PM – 3:15 PM | The Role of Industry in Clinical Trials Speaker: Ludy Shih, MD, MMSc, FANA | Beth Israel Deaconess Medical Center |
Adjourn |
CME INFORMATION
The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Neurological Association designates this live activity for a maximum of 7.25 AMA PRA Category 1 Creditsᵀᴹ. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTION FOR OBTAINING CME
All attendees will receive an email after the Annual Meeting ends with a link and instructions on how to download the Certificate of Attendance. Individuals who obtain the Certificate of Attendance/CME certificate on or before November 7, 2025, will be entered into a drawing for a $100 Starbucks card! Attendees may claim the Certificate of Attendance/CME certificate through December 31, 2025. If you have questions or would like additional information about claiming CME, please email Jen Hurley at [email protected].
FINANCIAL DISCLOSURE STATEMENTS
There are no relevant relationships for this activity.